Advertisement

IDXX

IDEXX Laboratories, Inc.

Healthcare · USD

Set alert

Price alert · IDXX

All alert types
551.21 USD -24.77 -4.30%
As of Oct 30, 2026 Extended hours 538.70 -2.27%
Bid
551.30 × 1
Ask
551.82 × 2
540.61 Day range 586.00
504.70 52-week range 766.68
YTD
-18.52%
1 year
-12.30%
Open
583.75
Prev close
575.98
Mkt cap
43.42B
Vol
1.17M
Avg vol
544.63K
EPS
14.23
P/E
38.74
Div yield
0.00%
More statistics
Low
540.61
High
586.00
Forward P/E
32.92
Beta
1.55
Short ratio
3.68
Inst. own
96.60%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
534.16
200-d avg
573.42
1y target
694.42

5D chart

Chart tools
Interval
IDXX five-day price chart540.6552.0563.3574.7586.0Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
43.48B
Enterprise value
46.28B
Trailing P/E
38.74
Forward P/E
32.92
PEG ratio
3.15
Price / sales
9.55
Price / book
26.96
EPS (TTM)
14.23
Beta
1.55
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
25.03%
Revenue (TTM)
4.55B
Revenue growth
9.70%
Free cash flow
909.37M
Total cash
196.93M
Total debt
1.10B
Return on equity
74.21%
Shares outstanding
78.88M
Short % of float
2.80%
50-day average
534.16
200-day average
573.42

Analyst view

Consensus: buy

Buy
Price target (mean) 694.42 +26.0% upside
Target (low)
470.00
Target (mean)
694.42
Target (high)
805.00
Ratings (0m) 14 9 buy · 4 hold · 1 sell
  • Strong buy4
  • Buy5
  • Hold4
  • Sell0
  • Strong sell1

Next earnings

Nov 2, 2026

Expected Nov 2, 2026. Consensus EPS estimate 3.71.

Earnings history

Financials — quick view

All financials
IDXX Revenue — quarterly 1.22B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
IDXX Net income — quarterly 338.41M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
IDXX EPS — quarterly 4.29
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

IDXX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 2, 2026Sep 30, 20263.73———
Aug 4, 2026Jun 30, 20263.944.27+0.33+8.38%
May 5, 2026Mar 31, 20263.413.47+0.06+1.76%
Feb 2, 2026Dec 31, 20252.933.08+0.15+5.12%
Nov 3, 2025Sep 30, 20253.143.40+0.26+8.28%
Aug 4, 2025Jun 30, 20253.283.63+0.35+10.67%

Upgrades / downgrades

IDXX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 27, 2026UBSmainNeutralNeutral
Oct 16, 2026JP MorganmainOverweightOverweight
Oct 12, 2026Keybancinit—Sector Weight
Aug 11, 2026BarclaysmainOverweightOverweight
Aug 5, 2026UBSmainNeutralNeutral
Aug 5, 2026CitigroupmainNeutralNeutral

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
idexx.com

News

Your note

Sign in to keep a note on IDXX — it syncs with the Stock Master app.

Insider holders

IDXX insider holders
InsiderRelationLatest transactionDateShares held
EMERSON ANDREWChief Financial OfficerConversion of Exercise of derivative securityAug 19, 20264,421
ERICKSON MICHAEL GOfficerConversion of Exercise of derivative securityFeb 18, 202615,092
FENNELL GEORGEOfficerConversion of Exercise of derivative securityMay 31, 202610,433
HUNT NIMRATA KOfficerSaleMar 2, 202618,300
KINGSLEY LAWRENCE DDirectorSaleSep 3, 20269,568
LANE MICHAEL JOfficerConversion of Exercise of derivative securityFeb 12, 20268,615

Institution ownership

IDXX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.37%8,170,1784.50BJun 29, 2026
Vanguard Capital Management LLC6.54%5,152,2132.84BJun 29, 2026
Vanguard Portfolio Management LLC4.95%3,896,5212.15BJun 29, 2026
State Street Corporation4.76%3,748,6602.07BJun 29, 2026
Invesco Ltd.4.58%3,611,4161.99BJun 29, 2026
Geode Capital Management, LLC3.25%2,562,8861.41BJun 29, 2026

Fund ownership

IDXX fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%2,504,3271.38BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%2,043,0871.13BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.17%1,709,209942.13MJun 29, 2026
Invesco QQQ Trust, Series 12.09%1,645,067906.78MSep 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%1,050,026578.78MSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%1,023,972564.42MAug 30, 2026
Advertisement